로딩 중…
지수 로딩 중…
텔콘RF제약
200230· KOSDAQ· Information Technology· Technology Hardware & Equipment
₩2,175+2.35%
2026-08-04
Financials
Valuation Metrics
텔콘RF제약's Market Cap is ₩206B. At end of 2025 it was ₩726B. Ranked #2300 of 2,436 in KR market (top 94%), #1524 of 1,649 on KOSDAQ (top 92%), #230 of 246 in Technology Hardware & Equipment (top 93%) by Market Cap.
Investment Metrics(as of 2026-08-04)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 20.62B KRW | KR#2,300/2,436 Sec#230/246 |
| Revenue | 42.88B KRW | KR#1,856/2,436 Sec#191/246 |
| Net Income | -8.30B KRW | KR—/2,436 Sec—/246 |
| Total Assets | 150.39B KRW | KR#1,470/2,436 Sec#135/246 |
| Net Assets | 97.42B KRW | KR#1,420/2,436 Sec#132/246 |
| Employees | 133 | KR#1,408/2,436 Sec#118/246 |
| Value | ||
| P/B | 0.21x | KR#134/2,436 Sec#9/246 |
| P/S | 0.48x | KR#907/2,436 Sec#88/246 |
| EV/EBITDA | 63.73x | KR#1,400/2,436 Sec#129/246 |
| FCF Yield | 6.53% | KR#780/2,436 Sec#67/246 |
| Profitability | ||
| ROE | -8.52% | KR#1,867/2,436 Sec#186/246 |
| ROA | -5.52% | KR#1,917/2,436 Sec#192/246 |
| Op. Margin | 1.85% | KR#1,374/2,436 Sec#124/246 |
| Revenue Growth | -2.85% | KR#1,606/2,436 Sec#155/246 |
| Financial Health | ||
| Debt Ratio | 154.37% | KR#1,251/2,436 Sec#131/246 |
| Total Debt | 38.00B KRW | KR#1,093/2,436 Sec#100/246 |
| FCF | 1.35B KRW | KR#1,123/2,436 Sec#97/246 |
| Cash | 7.96B KRW | KR#1,801/2,436 Sec#187/246 |
| Current Ratio | 1.24x | KR#1,538/2,436 Sec#171/246 |
| Net Debt/EBITDA | 37.78x | KR#1,512/2,436 Sec#143/246 |
| Performance | ||
| 1Y Return | -85.47% | KR#2,421/2,436 Sec#245/246 |
| 1M Return | 3.82% | KR#552/2,436 Sec#62/246 |
| From 52W High | -94.08% | KR#2,435/2,436 Sec#246/246 |
| 1Y MDD | -94.20% | KR#2,431/2,436 Sec#246/246 |
| Trading | ||
| Volume | 29,900 shares | KR#1,650/2,436 Sec#175/246 |
| Trading Value | 64.1M KRW | KR#1,941/2,436 Sec#198/246 |
| Foreign Own. | 4.80% | KR#818/2,436 Sec#87/246 |
| Per Share | ||
| EPS | -1,468 KRW | KR—/2,436 Sec—/246 |
| BPS | 14,191 KRW | KR#690/2,436 Sec#45/246 |
Company Info
동사는 1999년 설립되어 RF사업과 완제의약품 제조업을 병행하며 2014년 코스닥에 상장함. 제약·바이오 부문은 KGMP 생산시설을 바탕으로 다양한 제형의 제품을 생산하고 외주생산을 통해 매출 확대 및 신약개발에 투자하고 있음. RF부문은 광 사업장을 확대하며 광전복합 커넥터와 광Cable Ass’y 공급을 통해 광 솔루션 업체로 도약을 준비하고 5G 관련 솔루션 및 동남아시아 시장 진출을 통해 경쟁력 강화에 집중하고 있음. 텔콘RF제약는 1999년에 설립되었으며 경기도 용인시에 본사를 두고 있습니다.